Afrikaans Afrikaans Albanian Albanian Amharic Amharic Arabic Arabic Armenian Armenian Azerbaijani Azerbaijani Basque Basque Belarusian Belarusian Bengali Bengali Bosnian Bosnian Bulgarian Bulgarian Catalan Catalan Cebuano Cebuano Chichewa Chichewa Chinese (Simplified) Chinese (Simplified) Chinese (Traditional) Chinese (Traditional) Corsican Corsican Croatian Croatian Czech Czech Danish Danish Dutch Dutch English English Esperanto Esperanto Estonian Estonian Filipino Filipino Finnish Finnish French French Frisian Frisian Galician Galician Georgian Georgian German German Greek Greek Gujarati Gujarati Haitian Creole Haitian Creole Hausa Hausa Hawaiian Hawaiian Hebrew Hebrew Hindi Hindi Hmong Hmong Hungarian Hungarian Icelandic Icelandic Igbo Igbo Indonesian Indonesian Irish Irish Italian Italian Japanese Japanese Javanese Javanese Kannada Kannada Kazakh Kazakh Khmer Khmer Korean Korean Kurdish (Kurmanji) Kurdish (Kurmanji) Kyrgyz Kyrgyz Lao Lao Latin Latin Latvian Latvian Lithuanian Lithuanian Luxembourgish Luxembourgish Macedonian Macedonian Malagasy Malagasy Malay Malay Malayalam Malayalam Maltese Maltese Maori Maori Marathi Marathi Mongolian Mongolian Myanmar (Burmese) Myanmar (Burmese) Nepali Nepali Norwegian Norwegian Pashto Pashto Persian Persian Polish Polish Portuguese Portuguese Punjabi Punjabi Romanian Romanian Russian Russian Samoan Samoan Scottish Gaelic Scottish Gaelic Serbian Serbian Sesotho Sesotho Shona Shona Sindhi Sindhi Sinhala Sinhala Slovak Slovak Slovenian Slovenian Somali Somali Spanish Spanish Sundanese Sundanese Swahili Swahili Swedish Swedish Tajik Tajik Tamil Tamil Telugu Telugu Thai Thai Turkish Turkish Ukrainian Ukrainian Urdu Urdu Uzbek Uzbek Vietnamese Vietnamese Welsh Welsh Xhosa Xhosa Yiddish Yiddish Yoruba Yoruba Zulu Zulu

 

 

Article Navigation

Back To Main Page


 

Click Here for more articles

Google
The Right Focus on Tort Reform
by: Richard Martin
The recent headlines about Merck's Vioxx withdrawal and the FDA's move to ban ephedra have brought a lot of media attention to the growing area of drug litigation.
On April 12, 2004 the FDA published a rule banning health supplements that contain ephedra alkaloids. The FDA concluded that the limited short term weight loss effects were outweighed by possible heart problems and stroke risks. The market gap caused by the banning of ephedra has been filled by many new companies that are marketing products similar to ephedra. However, these “ephedra alternatives” may not be any safer than the banned ephedra that they replace.
The FDA's ephedra ban, and Merck's Vioxx withdrawal have been hot news topics. These drug recalls and ephedra banning have brought lawsuits from many different angles. Obviously, some people think that some of the lawsuits will be frivolous. In fact, there has been a lot of news during the last decade about “frivolous lawsuits” brought by injured consumers against large companies for defective products. However, according to one report from Public Citizen (http://www.citizen.org/congress/civjus/tort/myths/articles.cfm?ID=12369 ), businesses file many more times the amount of lawsuits than consumers do and are more likely to be sanctioned by a court for bringing a frivolous claim.
State governments have enacted tort reform which has capped potential damages for certain types of claims in some states. George W. Bush's state of Texas implemented tort reform in 2003 to cap medical malpractice liability. George W. Bush has continued to push for tort reform nationwide since he took office.
The real question is, if businesses are the ones who are generally taking too much of our courts' time- why has there been such a push for individual tort reform? Is it possible that injured individuals are not a group of organized people with continuous business interests that actively lobby for tort reform? While frivolous lawsuits are a concern for everyone, shouldn't tort reform really focus on the parties who are bringing most of them?

_________________

You may reproduce this article on your website. We would appreciate a link back to our site which has Vioxx articles and personal injury resources. This article may not be altered and links should be kept live. Thanks.

ABOUT THE AUTHOR
Richard Martin is a contributing writer at LegalClips.com. LegalClips.com has Personal Injury articles. LegalClips.com is a collection of lawyer articles and other resources.

 



©2005 - All Rights Reserved

Total Views stat / Page Views stat

Advertise Here

web page counter